Skip to Main Content

Author Details

Anne Hakem
Princess Margaret Cancer Centre, University Health Network
1996
38
27
PMIDPaper TitleJournal TitlePublished Year
36928661Excessive transcription-replication conflicts are a vulnerability of BRCA1-mutant cancers.Nucleic Acids Res2023
37697435RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells.Nucleic Acids Res2023
34196309Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis.J Clin Invest2021
33529165RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.J Clin Invest2021
30222135Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis.J Clin Invest2018
26876210Rad54 and Mus81 cooperation promotes DNA damage repair and restrains chromosome missegregation.Oncogene2016
27558965RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation.Nat Commun2016
24858046Cooperation of Blm and Mus81 in development, fertility, genomic integrity and cancer suppression.Oncogene2015
25736236INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia.Leukemia2015
23382699Synergistic interaction of Rnf8 and p53 in the protection against genomic instability and tumorigenesis.PLoS Genet2013
24324146RNF168 ubiquitylates 53BP1 and controls its response to DNA double-strand breaks.Proc Natl Acad Sci U S A2013
23966173Pirh2: an E3 ligase with central roles in the regulation of cell cycle, DNA damage response, and differentiation.Cell Cycle2013
23449389The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover.Cell Death Differ2013
22343728Caspase-8 is essential for maintaining chromosomal stability and suppressing B-cell lymphomagenesis.Blood2012
21552324Genomic instability, defective spermatogenesis, immunodeficiency, and cancer in a mouse model of the RIDDLE syndrome.PLoS Genet2011
22006951Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-/- mice.J Cell Biol2011
22125490Role of Pirh2 in mediating the regulation of p53 and c-Myc.PLoS Genet2011
21791603Pirh2 E3 ubiquitin ligase monoubiquitinates DNA polymerase eta to suppress translesion DNA synthesis.Mol Cell Biol2011
21625617Inactivation of chk2 and mus81 leads to impaired lymphocytes development, reduced genomic instability, and suppression of cancer.PLoS Genet2011
20385750Rnf8 deficiency impairs class switch recombination, spermatogenesis, and genomic integrity and predisposes for cancer.J Exp Med2010
20696928Dysregulation of the mevalonate pathway promotes transformation.Proc Natl Acad Sci U S A2010
19008920Essential role for Bclaf1 in lung development and immune system function.Cell Death Differ2009
17213198Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling.J Biol Chem2007
17875692Functional interplay of p53 and Mus81 in DNA damage responses and cancer.Cancer Res2007
16107613RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.Genes Dev2005
15131084Collaboration of Brca1 and Chk2 in tumorigenesis.Genes Dev2004
15343267Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity.EMBO J2004
12654726Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity.Genes Dev2003
12970760Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity.Nat Immunol2003
10881179Brca1 required for T cell lineage development but not TCR loci rearrangement.Nat Immunol2000
10528193In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes.J Immunol1999
10075979The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis.J Exp Med1999
9708736Differential requirement for caspase 9 in apoptotic pathways in vivo.Cell1998
9512515Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.Genes Dev1998
9753321Apaf1 is required for mitochondrial pathways of apoptosis and brain development.Cell1998
9285409The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes.Immunity1997
8598042Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice.Cell1996
8674108The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.Cell1996
  • 1 - 38 of 38

Recommended Authors

Oncology R&D
Career Start Year 2010
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 8
Gustave Roussy Cancer Center, INSERM U1170
Career Start Year 2002
Number of shared co-authors 0
University of Virginia
Career Start Year 2001
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2000
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Salk Institute for Biological Studies
Career Start Year 1998
Number of shared co-authors 0
University of Wisconsin-Madison School of Medicine and Public Health
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 0
AbbVie Inc.
Career Start Year 1995
Number of shared co-authors 0
Department of Pediatrics Stanford University Stanford California USA.
Career Start Year 1993
Number of shared co-authors 1
Case Western Reserve University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 1
University of Colorado Anschutz Medical Campus
Career Start Year 1991
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1991
Number of shared co-authors 0
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 1
The Institute of Cancer Research
Career Start Year 1988
Number of shared co-authors 0
University of Toronto
Career Start Year 1988
Number of shared co-authors 4
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 0
Institut de recherches cliniques de Montreal
Career Start Year 1985
Number of shared co-authors 0
University of Cambridge, Hutchison Research Centre
Career Start Year 1982
Number of shared co-authors 0
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 5
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 3
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1981
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 1978
Number of shared co-authors 2
Baylor College of Medicine
Career Start Year 1975
Number of shared co-authors 0

Collaborators

Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 33
Ontario Tech University
Co-authored papers 16
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 12
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 10
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
University of Sao Paulo
Co-authored papers 5
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Co-authored papers 5
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Schroeder Arthritis Institute
Co-authored papers 4
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 3
University of Toronto
Co-authored papers 3
University Health Network
Co-authored papers 2
University of Toronto
Co-authored papers 2
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 2
Schroeder Arthritis Institute
Co-authored papers 2
Children's Hospital Research Foundation
Co-authored papers 2
University of California los angeles
Co-authored papers 2
The Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital
Co-authored papers 2
University of Toronto
Co-authored papers 2
Co-authored papers 1
Fred Hutchinson Cancer Research Center
Co-authored papers 1
Co-authored papers 1
3Allergan Inc.,Markham,Ontario,Canada.
Co-authored papers 1
West Virginia University
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
b Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
University of Toronto
Co-authored papers 1
Gladstone Institutes of Cardiovascular Disease, Gladstone Institutes
Co-authored papers 1